Strados Labs

01/22/2026

Save the date: SCOPE Summit | February 2–5 | Orlando

Now in its 17th year, SCOPE 365 brings together leaders across pharma, biotech, CROs, sites, and technology to discuss how clinical trials are evolving amid increasing complexity, data demands, and patient expectations.

Our CEO & Founder Nick Delmonico and Global Director Shane Krauss plan to attend and look forward to exchanging perspectives on how real-world data, digital tools, and new monitoring approaches can support more effective, patient-centered endpoints.

Register for the event at: https://www.scopesummit.com/

01/19/2026

Today we recognize Martin Luther King Jr. and reflect on his leadership, courage, and commitment to justice and equality.

Dr. King's work reminds us of the importance of integrity, responsibility, and showing up for others—values that remain relevant across communities.

01/14/2026

Protecting Patient Privacy: Built Into Our Technology

At Strados Labs, privacy isn’t an afterthought. It’s built into the RESP® Platform from the start. Designed to capture internal lung sounds, our biosensor avoids ambient noise and background speech common with free-field mics in phones or wearables.

We add further safeguards with:
• Speech obfuscation in our cloud platform using voice activity detection (VAD) filters and other methods to remove incidental speech
• End-to-end encryption to secure data in transit and at rest

These protections ensure we advance respiratory care while safeguarding patient confidentiality and trust.

Learn more: https://stradoslabs.com/

01/12/2026

Strados Labs will be in San Francisco this week, January 12–15, for the 44th Annual JPM Healthcare Conference, a week when the entire healthcare ecosystem seems to converge in one place!

JPM has long been a place where investment, innovation, and real momentum in healthcare converge. This year’s conversations are expected to focus heavily on how emerging technologies, particularly AI-driven approaches, are shaping drug development, diagnostics, and scalable digital health solutions.

We’re looking forward to connecting with industry leaders, innovators, and investors who are thinking deeply about how objective, real-world data can strengthen clinical research, support better decision-making, and ultimately improve patient outcomes, especially in respiratory health.

If you’ll be in San Francisco for JPM, let’s connect! https://www.jpmorgan.com/about-us/events-conferences/health-care-conference

We aim to be the most respected financial services firm in the world, serving corporations and individuals in more than 100 countries.

01/08/2026

We’re heading to San Francisco next week for one of the most important events in healthcare.

Nick Delmonico, CEO and Co-founder of Strados Labs, will be attending the J.P. Morgan Healthcare Conference from January 12–15.

Nick will be on the ground connecting with industry leaders, investors, and partners to discuss innovation in respiratory monitoring, digital health, and clinical research. If you’ll be there and would like to connect, please feel free to message him!

01/06/2026

ICYMI: Cough is becoming a digital endpoint in more clinical trials, but how cough events are processed is just as important as the devices capturing them.

Our recent whitepaper outlines a key design decision for sponsors and research teams: choosing between edge processing (on-device, real-time ML analysis) and cloud processing (analysis of raw audio on secure servers with ML + human review).

As the paper explains, this choice carries significant implications for scientific integrity, regulatory acceptance, and the ability to conduct retrospective quality checks. Cloud processing retains raw audio, supports FDA-recognized human annotation, and enables full audit trails—capabilities essential for reliable, defensible clinical data.

Read the whitepaper: https://stradoslabs.com/data-processing-architectures-for-cough-monitoring-the-case-for-cloud-processing/

This whitepaper highlights an important yet often overlooked aspect of cough monitoring: the data processing architecture that supports how cough events are

12/31/2025

"Happy New Year from all of us at Strados Labs! Wishing you a healthy, happy start to 2026 and a year filled with growth and new opportunities.

#2026

12/23/2025

The holiday season is a welcome reminder of the joy in community, compassion, and our shared commitment to improving respiratory health.

Wishing everyone a warm, restful, and joyful holiday season spent with the people who matter most!

12/17/2025

According to MD+DI, key trends expected to shape the med tech industry in 2026 include the growth of AI-enabled devices, the rising importance of real-world data, and more accessible, consumer-focused health monitoring. Read the full article: https://bit.ly/3YdIkEB

At Strados Labs, these trends reflect the work already underway. Our RESP technology supports automated, continuous respiratory monitoring, providing real-world insights that help clinical and research teams better evaluate respiratory status and treatment response.

As the industry moves toward smarter, more patient-centric technologies, we remain focused on advancing objective measurement to improve respiratory disease surveillance and management.

Adam Hesse, CEO of Full Spectrum, discusses the transformative trends shaping the medtech industry.

12/09/2025

Today we’re celebrating a major milestone in making every breath count: the RESP® Biosensor has officially captured 50 million breaths!

This achievement wouldn’t be possible without our research collaborations in 2025, from academic medical centers, pediatric and adult hospitals, and pharmaceutical companies who have partnered with us to strengthen insight into patient treatment response and respiratory status.

Here’s to the next 50 million breaths and to continuing to make every breath count!

12/04/2025

Cough is one of the most distressing and persistent symptoms for people living with bronchiectasis.

Persistent cough often reflects mucus burden, airway inflammation, and ongoing exacerbation risk. Yet, in both routine care and clinical research, cough is still frequently assessed through patient recall alone.

As new therapies emerge, understanding cough patterns with greater clarity can help better characterize disease progression, treatment response, and patient quality of life.

Learn why cough matters in bronchiectasis and how objective cough measurement can advance care and clinical research: https://stradoslabs.com/bronchiectasis/

12/02/2025

Respiratory virus season has arrived, and cases of COVID-19, influenza, and RSV are expected to rise as colder months set in.

According to the CDC’s 2025–26 outlook, hospitalizations are projected to reach levels similar to last season. Public health experts emphasize vaccination as the best protection—especially for older adults, children, and those with chronic respiratory conditions. Read more from ABC News: https://bit.ly/3JPa66L

As respiratory viruses continue to challenge healthcare systems, tools like our RESP® Biosensor that support prevention, early detection, and ongoing monitoring remain critical for improving outcomes.

Here's what to know about the COVID-19, flu and RSV vaccines available for respiratory virus season including who is eligible and where to get them.